{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T21:32:59Z","timestamp":1777066379205,"version":"3.51.4"},"reference-count":48,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82273948"],"award-info":[{"award-number":["82273948"]}]},{"name":"National Natural Science Foundation of China","award":["2021B0909050003"],"award-info":[{"award-number":["2021B0909050003"]}]},{"name":"National Natural Science Foundation of China","award":["CASIMM0120225003-1 and -2"],"award-info":[{"award-number":["CASIMM0120225003-1 and -2"]}]},{"name":"National Natural Science Foundation of China","award":["SKLDR-2023-TT-01"],"award-info":[{"award-number":["SKLDR-2023-TT-01"]}]},{"name":"High-level Innovative Research Institute, Department of Science and Technology of Guangdong Province","award":["82273948"],"award-info":[{"award-number":["82273948"]}]},{"name":"High-level Innovative Research Institute, Department of Science and Technology of Guangdong Province","award":["2021B0909050003"],"award-info":[{"award-number":["2021B0909050003"]}]},{"name":"High-level Innovative Research Institute, Department of Science and Technology of Guangdong Province","award":["CASIMM0120225003-1 and -2"],"award-info":[{"award-number":["CASIMM0120225003-1 and -2"]}]},{"name":"High-level Innovative Research Institute, Department of Science and Technology of Guangdong Province","award":["SKLDR-2023-TT-01"],"award-info":[{"award-number":["SKLDR-2023-TT-01"]}]},{"name":"Institutes for Drug Discovery and Development, the Chinese Academy of Sciences","award":["82273948"],"award-info":[{"award-number":["82273948"]}]},{"name":"Institutes for Drug Discovery and Development, the Chinese Academy of Sciences","award":["2021B0909050003"],"award-info":[{"award-number":["2021B0909050003"]}]},{"name":"Institutes for Drug Discovery and Development, the Chinese Academy of Sciences","award":["CASIMM0120225003-1 and -2"],"award-info":[{"award-number":["CASIMM0120225003-1 and -2"]}]},{"name":"Institutes for Drug Discovery and Development, the Chinese Academy of Sciences","award":["SKLDR-2023-TT-01"],"award-info":[{"award-number":["SKLDR-2023-TT-01"]}]},{"name":"State Key Laboratory of Drug Research","award":["82273948"],"award-info":[{"award-number":["82273948"]}]},{"name":"State Key Laboratory of Drug Research","award":["2021B0909050003"],"award-info":[{"award-number":["2021B0909050003"]}]},{"name":"State Key Laboratory of Drug Research","award":["CASIMM0120225003-1 and -2"],"award-info":[{"award-number":["CASIMM0120225003-1 and -2"]}]},{"name":"State Key Laboratory of Drug Research","award":["SKLDR-2023-TT-01"],"award-info":[{"award-number":["SKLDR-2023-TT-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>IRAK4 is a critical mediator in NF-\u03baB-regulated inflammatory signaling and has emerged as a promising therapeutic target for the treatment of autoimmune diseases; however, none of its inhibitors have received FDA approval. In this study, we identified a novel small-molecule IRAK4 kinase inhibitor, DW18134, with an IC50 value of 11.2 nM. DW18134 dose-dependently inhibited the phosphorylation of IRAK4 and IKK in primary peritoneal macrophages and RAW264.7 cells, inhibiting the secretion of TNF-\u03b1 and IL-6 in both cell lines. The in vivo study demonstrated the efficacy of DW18134, significantly attenuating behavioral scores in an LPS-induced peritonitis model. Mechanistically, DW18134 reduced serum TNF-\u03b1 and IL-6 levels and attenuated inflammatory tissue injury. By directly blocking IRAK4 activation, DW18134 diminished liver macrophage infiltration and the expression of related inflammatory cytokines in peritonitis mice. Additionally, in the DSS-induced colitis model, DW18134 significantly reduced the disease activity index (DAI) and normalized food and water intake and body weight. Furthermore, DW18134 restored intestinal damage and reduced inflammatory cytokine expression in mice by blocking the IRAK4 signaling pathway. Notably, DW18134 protected DSS-threatened intestinal barrier function by upregulating tight junction gene expression. In conclusion, our findings reported a novel IRAK4 inhibitor, DW18134, as a promising candidate for treating inflammatory diseases, including peritonitis and IBD.<\/jats:p>","DOI":"10.3390\/molecules29081803","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T04:21:59Z","timestamp":1713241319000},"page":"1803","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Novel IRAK4 Inhibitor DW18134 Ameliorates Peritonitis and Inflammatory Bowel Disease"],"prefix":"10.3390","volume":"29","author":[{"given":"Yuqing","family":"Huang","sequence":"first","affiliation":[{"name":"Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China"},{"name":"College of Pharmacy, Guizhou Medical University, Guiyang 561113, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Ning","sequence":"additional","affiliation":[{"name":"Division of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China"},{"name":"University of Chinese Academy of Sciences, Beijing 100049, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[{"name":"University of Chinese Academy of Sciences, Beijing 100049, China"},{"name":"Small-Molecule Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiran","family":"Song","sequence":"additional","affiliation":[{"name":"Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China"},{"name":"Division of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haotian","family":"Tang","sequence":"additional","affiliation":[{"name":"Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China"},{"name":"Division of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhao","family":"Shi","sequence":"additional","affiliation":[{"name":"Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Wan","sequence":"additional","affiliation":[{"name":"Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gege","family":"Huang","sequence":"additional","affiliation":[{"name":"Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiupei","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China"},{"name":"Department of Chemical and Environment Engineering, Science and Engineering Building, The University of Nottingham Ningbo China, Ningbo 315100, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[{"name":"Small-Molecule Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuantong","family":"Li","sequence":"additional","affiliation":[{"name":"Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengsheng","family":"Zhan","sequence":"additional","affiliation":[{"name":"Small-Molecule Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Ding","sequence":"additional","affiliation":[{"name":"Division of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhu","family":"Duan","sequence":"additional","affiliation":[{"name":"University of Chinese Academy of Sciences, Beijing 100049, China"},{"name":"Small-Molecule Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Xie","sequence":"additional","affiliation":[{"name":"Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China"},{"name":"College of Pharmacy, Guizhou Medical University, Guiyang 561113, China"},{"name":"Division of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China"},{"name":"University of Chinese Academy of Sciences, Beijing 100049, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrd.2016.39","article-title":"Resolution of inflammation: A new therapeutic frontier","volume":"15","author":"Fullerton","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.cgh.2020.01.028","article-title":"Changing Global Epidemiology of Inflammatory Bowel Diseases: Sustaining Health Care Delivery Into the 21st Century","volume":"18","author":"Ananthakrishnan","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/advances\/nmab037","article-title":"The Dietary Inflammatory Index and Human Health: An Umbrella Review of Meta-Analyses of Observational Studies","volume":"12","author":"Marx","year":"2021","journal-title":"Adv. Nutr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41573-020-0082-8","article-title":"Kinase inhibition in autoimmunity and inflammation","volume":"20","author":"Zarrin","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s002689900364","article-title":"Tertiary peritonitis: Clinical features of a complex nosocomial infection","volume":"22","author":"Nathens","year":"1998","journal-title":"World J. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e39568","DOI":"10.2196\/39568","article-title":"Peritoneal Dialysis Care in Mainland China: Nationwide Survey","volume":"9","author":"Li","year":"2023","journal-title":"JMIR Public Health Surveill."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"M12","DOI":"10.12968\/hmed.2008.69.Sup1.28050","article-title":"Peritonitis","volume":"69","author":"Spalding","year":"2008","journal-title":"Br. J. Hosp. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/path.4942","article-title":"The peritoneum: Healing, immunity, and diseases","volume":"243","author":"Capobianco","year":"2017","journal-title":"J. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","article-title":"TNF alpha and the TNF receptor superfamily: Structure-function relationship(s)","volume":"50","author":"Idriss","year":"2000","journal-title":"Microsc. Res. Tech."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s00134-002-1383-6","article-title":"Future directions in the management of tertiary peritonitis","volume":"28","author":"Buijk","year":"2002","journal-title":"Intensive Care Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/jgh.12859","article-title":"Emerging leadership lecture: Inflammatory bowel disease in Asia: Emergence of a \u201cWestern\u201d disease","volume":"30","author":"Ng","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.crohns.2013.01.010","article-title":"The burden of inflammatory bowel disease in Europe","volume":"7","author":"Burisch","year":"2013","journal-title":"J. Crohns Colitis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/gutjnl-2013-304636","article-title":"East-West gradient in the incidence of inflammatory bowel disease in Europe: The ECCO-EpiCom inception cohort","volume":"63","author":"Burisch","year":"2014","journal-title":"Gut"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41575-023-00769-0","article-title":"Macrophages in intestinal homeostasis and inflammatory bowel disease","volume":"20","author":"Hegarty","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41575-019-0172-4","article-title":"Macrophages in intestinal inflammation and resolution: A potential therapeutic target in IBD","volume":"16","author":"Na","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1042\/CS20040136","article-title":"Host-bacterial interactions in inflammatory bowel disease","volume":"107","author":"Mahida","year":"2004","journal-title":"Clin. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.molmed.2023.01.001","article-title":"IBD disease-modifying therapies: Insights from emerging therapeutics","volume":"29","author":"Kotla","year":"2023","journal-title":"Trends Mol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/2050640619840147","article-title":"Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review","volume":"7","author":"Zoubek","year":"2019","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"15208","DOI":"10.1074\/jbc.RA118.003831","article-title":"Mechanism of dysfunction of human variants of the IRAK4 kinase and a role for its kinase activity in interleukin-1 receptor signaling","volume":"293","author":"De","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20061825","article-title":"A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity","volume":"204","author":"Kim","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/art.41953","article-title":"The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial","volume":"73","author":"Winkler","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"eabj3289","DOI":"10.1126\/scitranslmed.abj3289","article-title":"IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases","volume":"15","author":"Lavazais","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"175593","DOI":"10.1016\/j.ejphar.2023.175593","article-title":"A small molecule potent IRAK4 inhibitor abrogates lipopolysaccharide-induced macrophage inflammation in-vitro and in-vivo","volume":"944","author":"Choudhary","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"115453","DOI":"10.1016\/j.ejmech.2023.115453","article-title":"Design, synthesis and pharmacological evaluation of 2,3-dihydrobenzofuran IRAK4 inhibitors for the treatment of diffuse large B-cell lymphoma","volume":"256","author":"Chen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.4049\/jimmunol.162.3.1685","article-title":"Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: Evidence for an inhibitory loop involving endogenous IL-10","volume":"162","author":"Ajuebor","year":"1999","journal-title":"J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s10753-020-01286-x","article-title":"Rhoifolin Alleviates Inflammation of Acute Inflammation Animal Models and LPS-Induced RAW264.7 Cells via IKK\u03b2\/NF-\u03baB Signaling Pathway","volume":"43","author":"Fang","year":"2020","journal-title":"Inflammation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0023677215570087","article-title":"Lipopolysaccharide-induced inflammatory liver injury in mice","volume":"49","author":"Hamesch","year":"2015","journal-title":"Lab. Anim."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Li, Q., Li, R., Yin, H., Wang, S., Liu, B., Li, J., Zhou, M., Yan, Q., and Lu, L. (2022). Oral IRAK4 inhibitor BAY-1834845 prevents acute respiratory distress syndrome. Biomed. Pharmacother., 153.","DOI":"10.1016\/j.biopha.2022.113459"},{"key":"ref_31","unstructured":"Mizoguchi, A. (2012). Animal Models of Molecular Pathology, Academic Press. Progress in Molecular Biology and Translational Science."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"15.25.11","DOI":"10.1002\/0471142735.im1525s104","article-title":"Dextran sulfate sodium (DSS)-induced colitis in mice","volume":"104","author":"Chassaing","year":"2014","journal-title":"Curr. Protoc. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Yan, Y., Kolachala, V., Dalmasso, G., Nguyen, H., Laroui, H., Sitaraman, S.V., and Merlin, D. (2009). Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006073"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1038\/ctg.2016.54","article-title":"Human Intestinal Barrier Function in Health and Disease","volume":"7","author":"Wells","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00418-008-0424-9","article-title":"Tight junctions and the modulation of barrier function in disease","volume":"130","year":"2008","journal-title":"Histochem. Cell Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1073\/pnas.1006451107","article-title":"The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions","volume":"108","author":"Johansson","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"154091","DOI":"10.1016\/j.phymed.2022.154091","article-title":"Bupi Yichang Pill alleviates dextran sulfate sodium-induced ulcerative colitis in mice by regulating the homeostasis of follicular helper T cells","volume":"100","author":"Zhong","year":"2022","journal-title":"Phytomedicine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phymed.2015.11.003","article-title":"Vitexin reduces neutrophil migration to inflammatory focus by down-regulating pro-inflammatory mediators via inhibition of p38, ERK1\/2 and JNK pathway","volume":"23","author":"Rosa","year":"2016","journal-title":"Phytomedicine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0016-5085(03)00267-1","article-title":"Galectin-1 suppresses experimental colitis in mice","volume":"124","author":"Santucci","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/ueg2.12317","article-title":"Implications of the changing epidemiology of inflammatory bowel disease in a changing world","volume":"10","author":"Agrawal","year":"2022","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","article-title":"Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States","volume":"165","author":"Lewis","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.taap.2014.10.002","article-title":"Suppression of NF-\u03baB signaling and NLRP3 inflammasome activation in macrophages is responsible for the amelioration of experimental murine colitis by the natural compound fraxinellone","volume":"281","author":"Wu","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Nahidi, L., Leach, S.T., Mitchell, H.M., Kaakoush, N.O., Lemberg, D.A., Munday, J.S., Huinao, K., and Day, A.S. (2013). Inflammatory bowel disease therapies and gut function in a colitis mouse model. Biomed. Res. Int., 2013.","DOI":"10.1155\/2013\/909613"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41572-020-0153-5","article-title":"Colonic diverticular disease","volume":"6","author":"Tursi","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1084\/jem.20151074","article-title":"Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy","volume":"212","author":"Kelly","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.4049\/jimmunol.1600583","article-title":"Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity","volume":"198","author":"Dudhgaonkar","year":"2017","journal-title":"J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"eaaz1053","DOI":"10.1126\/scisignal.aaz1053","article-title":"The kinase IRAK4 promotes endosomal TLR and immune complex signaling in B cells and plasmacytoid dendritic cells","volume":"13","author":"Corzo","year":"2020","journal-title":"Sci. Signal"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Guidetti, F., Arribas, A.J., Sartori, G., Spriano, F., Barnabei, L., Tarantelli, C., Von Roemeling, R., Martinez, E., Zucca, E., and Bertoni, F. (2023). Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors. J. Clin. Med., 12.","DOI":"10.3390\/jcm12020399"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/8\/1803\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:28:31Z","timestamp":1760106511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/8\/1803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":48,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["molecules29081803"],"URL":"https:\/\/doi.org\/10.3390\/molecules29081803","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,16]]}}}